GlassScriptPhysician profile
Wilson T Asfora
NPI 1194706754
$1,338,339.81
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266K · 2020: $239K · 2021: $214K · 2022: $302K · 2023: $318K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $318K · Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $318,224.00 |
| Food and Beverage | $101.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $833,692.00 | 2021-2023 | |
| Medtronic USA, INC. | $456,429.89 | 2019-2020 | |
| Orthofix Medical, INC. | $47,716.25 | 2019 | |
| Stryker Corporation | $168.78 | 2019-2023 | |
| Spineguard, INC. | $91.24 | 2019 | |
| Abbott Laboratories | $72.51 | 2019 | |
| 4web, INC. | $54.71 | 2019 | |
| Tersera Therapeutics LLC | $49.73 | 2019 | |
| Merz North America, INC. | $18.00 | 2019 | |
| Adamas Pharmaceuticals, INC. | $17.25 | 2019 | |
| Captiva Spine INC | $15.81 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $13.64 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$662,403.27 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Asfora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.